Management of Coronary Disease in Patients with Advanced Kidney Disease | Zendy

Sripal Bangalore | Zendy; David J. Maron | Zendy; Sean M. O’Brien | Zendy; Jerome L. Fleg | Zendy; Еvgeny Kretov | Zendy; Carlo Briguori | Zendy; Upendra Kaul | Zendy; Harmony R. Reynolds | Zendy; Tomasz Mazurek | Zendy; Mandeep S. Sidhu | Zendy; Jeffrey S. Berger | Zendy; Roy O. Mathew | Zendy; O.L. Bockeria | Zendy; Samuel Broderick | Zendy; Radosław Pracoń | Zendy; Charles A. Herzog | Zendy; Zhen Huang | Zendy; Gregg W. Stone | Zendy; William E. Boden | Zendy; Jonathan Newman | Zendy; Ziad A. Ali | Zendy; Daniel B. Mark | Zendy; John A. Spertus | Zendy; Karen P. Alexander | Zendy; Bernard R. Chaitman | Zendy; Glenn M. Chertow | Zendy; Judith S. Hochman | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Management of Coronary Disease in Patients with Advanced Kidney Disease

Author(s) -

Sripal Bangalore,

David J. Maron,

Sean M. O’Brien,

Jerome L. Fleg,

Еvgeny Kretov,

Carlo Briguori,

Upendra Kaul,

Harmony R. Reynolds,

Tomasz Mazurek,

Mandeep S. Sidhu,

Jeffrey S. Berger,

Roy O. Mathew,

O.L. Bockeria,

Samuel Broderick,

Radosław Pracoń,

Charles A. Herzog,

Zhen Huang,

Gregg W. Stone,

William E. Boden,

Jonathan Newman,

Ziad A. Ali,

Daniel B. Mark,

John A. Spertus,

Karen P. Alexander,

Bernard R. Chaitman,

Glenn M. Chertow,

Judith S. Hochman

Publication year - 2020

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa1915925

Subject(s) - medicine , hazard ratio , myocardial infarction , revascularization , unstable angina , cardiology , kidney disease , angina , dialysis , stroke (engine) , incidence (geometry) , surgery , confidence interval , mechanical engineering , physics , optics , engineering

Among patients with stable coronary disease, advanced chronic kidney disease, and moderate or severe ischemia, we did not find evidence that an initial invasive strategy, as compared with an initial conservative strategy, reduced the risk of death or nonfatal myocardial infarction. (Funded by the National Heart, Lung, and Blood Institute and others; ISCHEMIA-CKD ClinicalTrials.gov number, NCT01985360.).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research